2019年2月28日星期四

The 3 Best REITs to Own as the Senior-Citizen Population Explodes

Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiving this email as a part of your subscription to Tim Melvin's Max Wealth. Your ability to alter your subscription information can be found at the bottom of this email.

Tim Melvin's Max Wealth

Whatever you had planned for tonight... this is better

This special broadcast is eight months in the making... we've invested millions of dollars in production, staff, and opportunity costs... all because we truly believe this can change your life. We believe that anyone who watches it can walk away knowing how to make an extra $30,000 a month - every month - for the rest of their life. And that this is absolutely the most important thing you will ever see. So cancel your plans, and view this special broadcast now.


February 28, 2019

The 3 Best REITs to Own as the Senior-Citizen Population Explodes
By Tim Melvin

Dear Reader,

One overlooked sector I've been keeping track of - and have been wildly bullish on - for years now is senior housing, so I was hardly surprised to hear about the sector's biggest merger news in years last June...

I'm talking about private-equity behemoth KKR & Co. LP (NYSE: KKR) buying Envision Healthcare Corp. (NYSE: EVHC) for $5.7 billion in cash, with the total deal value adding up to $9.9 billion including debt.

This was one of the largest leveraged buyouts of 2018.

Again, this isn't a shock to those of us who pay attention to what the private-equity folks are doing with their funds.

Despite the bad rep that private-equity firms sometimes get, their activity can often point to the direction of profits.

And they're currently pointing to one emerging trend set to hand three real estate investment trusts (REITs) - and their investors - a steady stream of profits over the next two decades...


Here's what else I'm following...
Brace Yourself: The 5G Revolution Is Unleashing Your Next TRILLION-DOLLAR Opportunity

In my three decades tracking the world's biggest technological breakthroughs, I've never seen anything as huge as this. This $6 company could be set to DOMINATE a $12 TRILLION market - and when that happens, you could be celebrating with 10 times your money. Go here to find out more.


You are receiving this e-mail at, its028@gmail.com, as a part of your free subscription to Tim Melvin's Max Wealth.

Remove your email from this list: Unsubscribe

Manage Your Email Preferences

To cancel by mail or for any other subscription issues, write us at:
Tim Melvin's Max Wealth | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201
North America: 888.384.8339; International: 443.353.4519; Fax: 410.622.3050
Contact Customer Service
Website: https://maxwealth.com/

© 2019 Tim Melvin's Max Wealth All Rights Reserved.
Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice.

We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Tim Melvin's Max Wealth. 1125 N Charles Street, Baltimore MD 21201.

没有评论:

发表评论